Details for Patent: 12,133,837
✉ Email this page to a colleague
Which drugs does patent 12,133,837 protect, and when does it expire?
Patent 12,133,837 protects ADRENALIN and is included in one NDA.
Drugs Protected by US Patent 12,133,837
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-001 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-002 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-003 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-004 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Endo Operations | ADRENALIN | epinephrine | SOLUTION;INTRAVENOUS | 215875-005 | Apr 21, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
